Genetic Signatures Ltd (GSS) — Cash Flow Reinvestment Rate

Latest as of June 2022: 1.32x

Genetic Signatures Ltd (GSS) has a Cash Flow Reinvestment Rate of 1.32x as of June 2022, reinvesting AU$2.55 Million (capex AU$2.55 Million ) from operating cash flow of AU$1.93 Million. Explore GSS capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

1.32x

(Capex + Investments) / Operating CF

Total Reinvested

AU$2.55 Million

Capex + Investments

Operating Cash Flow

AU$1.93 Million

AUD

Capital Expenditures

AU$2.55 Million

AUD

Genetic Signatures Ltd Cash Flow Reinvestment Rate (2021–2022)

Historical reinvestment intensity for Genetic Signatures Ltd across 2 annual periods. Also explore balance sheet size of Genetic Signatures Ltd for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Genetic Signatures Ltd (2021–2022)

Year-by-year capital reinvestment analysis for Genetic Signatures Ltd. For live market cap and broader valuation context, see market cap of Genetic Signatures Ltd.

Year	Reinvestment Rate	Total Reinvested (AUD)	Operating CF	Capex	YoY Change
2022	0.61x	AU$5.98 Million	AU$9.81 Million	AU$2.99 Million	▼ -74.3%
2021	2.37x	AU$9.96 Million	AU$4.20 Million	AU$4.98 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow